Skip to Content
MilliporeSigma
  • Visualization of nitric oxide production by individual platelets during adhesion in flowing blood.

Visualization of nitric oxide production by individual platelets during adhesion in flowing blood.

Blood (2014-12-07)
Maria Rita Cozzi, Giuseppe Guglielmini, Monica Battiston, Stefania Momi, Elisabetta Lombardi, Edward Cole Miller, Denise De Zanet, Mario Mazzucato, Paolo Gresele, Luigi De Marco
ABSTRACT

Nitric oxide (NO) exerts vasodilatatory, antiplatelet, antioxidant, and antiproliferative effects. Endothelium-derived NO has been shown to be of crucial importance in cardiovascular protection, whereas evidence that NO is synthesized by platelets and regulates platelet function is still controversial. By using a sensitive and specific fluorescent probe, 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM), we visualized NO production in individual platelets undergoing adhesion on a collagen substrate under flow conditions. NO production, monitored in real time, was dependent on the shear rates applied, increasing with the raising of the shear rates. Furthermore, NO production increased in the presence of l-arginine (nitric-oxide synthase [NOS] substrate), and it decreased in the presence of L-NG-monomethyl arginine (L-NMMA) (NOS inhibitor) but not of D-NG-monomethyl arginine (D-NMMA) (L-NMMA-inactive enantiomer). Platelet deposition, measured with mepacrine-labeled platelets, was inversely related to NO production. A correlation was evident between Ca(++) elevation and NO production, suggesting that platelet NO formation is triggered by intracytoplasmic Ca(++) elevation. Simultaneous measurement of NO and Ca(++) indicated that NO production in individual platelets is preceded by Ca(++) elevations, with a lag phase of 33 ± 9.5 s. Our studies provide the first direct demonstration of platelet NO production triggered by the interaction with an activating surface under flow and suggest that intraplatelet Ca(++) elevation elicits the production of NO which, in turn, modulates thrombus size.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, for molecular biology, ≥97.0%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, ≥97.0%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, BioXtra, ≥97 .0%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, BioUltra, for molecular biology, ≥99.0% (T)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Arginine, reagent grade, ≥98%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
NG-Methyl-L-arginine acetate salt, ≥98% (TLC)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Arginine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Arginine, BioUltra, ≥99.5% (NT)
SKU
Pack Size
Availability
Price
Quantity
SAFC
L-Arginine
SKU
Pack Size
Availability
Price
Quantity
Arginine, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Supelco
L-Arginine, Pharmaceutical Secondary Standard; Certified Reference Material
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Arginine, 99%, FCC, FG
SKU
Pack Size
Availability
Price
Quantity